Inverse dC (Bz) CNA CPG
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG for the incorporation of amino-C7 at the 3' end of an oligonucleotide, with Fmoc protection.
CPG for the incorporation of cholesterol at the 3' end of an oligonucleotide, with a triethylene glycol spacer.
CPG for incorporation of a locked nucleic acid G analogue at the 3' end of an oligonucleotide.
CPG for incorporation of a locked nucleic acid T analogue at the 3' end of an oligonucleotide.
CPG for incorporation of a 2'-O-methyl modified ribo-C nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG for the incorporation of a 2'-O-methyl modified ribo-A nucleobase at the 3' end of an oligonucleotide.
CPG for incorporation of unmodified ribo-C at 3' end of an oligonucleotide.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |